Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antihypertensive efficacy and safety of
Fimasartan (BR-A-657•K) 60 mg~120 mg in patients with mild to moderate essential
hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Collaborators:
Ajou University Asan Medical Center Cheil General Hospital and Women's Healthcare Center Cheil General Hospital and Women’s Healthcare Center Chonbuk National University Hospital Chungbuk National University Hospital Chungnam National University Dongguk University International Hospital Hanyang University Inha University Hospital Kangbuk Samsung Hospital Keimyung University Konkuk University Medical Center Konyang University Hospital Korea University Korea University Guro Hospital Samsung Medical Center Seoul National University Bundang Hospital Seoul National University Hospital Severance Hospital The Catholic University of Korea Wonju Christian Hospital Wonju Severance Christian Hospital Yeungnam University Yeungnam University Hospital Yonsei University